Researchers have announced “promising” results from an experimental compound that might provide a treatment for MLL-rearranged leukaemia in infants.
Rearrangement of the MLL gene – also known as KMT2A – is involved in up to 80% of cases of acute l...
6 months ago
I wonder what will be in the 10-year plan after Lord Darzi’s full and independent investigation into the state of the NHS, which is due to be reported next month. I’m rather fed up with hearing that the NHS is broken. The NHS staff’s intelligence,...
6 months ago
